Opportunities in Stem Cell TechnologyKalorama InformationFebruary 1, 2002 408 Pages - SKU: KLI504938 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2008-2009-2010 and 2011q2 for these measures:
|
more...
|
$699.00
|
|
2012 European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
4/24/2012 | published by: Venture Planning Group
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business
|
more...
|
$18,500.00
|
|
2012 Global Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
4/23/2012 | published by: Venture Planning Group
This comprehensive seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. Highlights Business and technological trends in seven major
|
more...
|
$28,500.00
|
|
Stem Cell Research Products: Opportunities, Tools, & Technologies
5/1/2012 | published by: BioInformant Worldwide, L.L.C.
Overview: With recent advances in induced pluripotent stem cells (iPSC) creating excitement in stem cell research circles and U.S. President Obama expanding the number of human embryonic stem cell lines (hESC) available for federally
|
more...
|
$3,495.00
|
|
Hematological Cancer Therapies
3/1/2012 | published by: CHI Insight Pharma Reports
In recent years, newer and more specific therapies for hematological cancers have been developed, such as targeted small-molecule drugs and biological therapies including monoclonal antibodies. However, there remains significant need from a clinical perspective, as
|
more...
|
$2,495.00
|
|
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than
|
more...
|
$3,000.00
|
|
Cancer Monoclonal Antibodies Market to 2015
3/1/2012 | published by: RNCOS
Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming
|
more...
|
$1,500.00
|
|
Global Biotechnology
4/4/2012 | published by: IBISWorld
Global Biotechnology Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living materials for the production of knowledge and biotechnology products and
|
more...
|
$935.00
|
|
Strategic Analysis of the U.S. Research Antibodies Market
3/30/2012 | published by: Frost & Sullivan
This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as assay components for
|
more...
|
$6,000.00
|
Related Markets
- Biotechnology
- Tissue Engineering
- Research & Development
- Antisense & RNAi Technology
- Genetic Engineering
- Stem Cell
- Pharmaceuticals
- Biopharmaceuticals
